Europe Mid-Size Pharmaceutical Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other Formulations), and Therapy Class (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, and Other Conditions)    

No. of Pages: 73    |    Report Code: BMIRE00026179    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Mid-Size Pharmaceutical Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Mid-Size Pharmaceutical Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Mid-Size Pharmaceutical Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Investment towards Improvement of Pharmaceutical Manufacturing Capabilities to boost the mid-size pharmaceutical market
5.2 Market Opportunities
  • 5.2.1 Active participation of market players in product innovation and developments fuel the growth of the mid-size pharmaceutical market
5.3 Future Trends
  • 5.3.1 Adoption of Tech Transfer and Outsourcing Trends providing a significant growth opportunity for the mid-size pharmaceutical market
5.4 Impact of Drivers and Restraints

6. Europe Mid-Size Pharmaceutical Market Regional Analysis

6.1 Europe Mid-Size Pharmaceutical Market Overview
6.2 Europe Mid-Size Pharmaceutical Market Revenue 2020-2028 (US$ Million)
6.3 Europe Mid-Size Pharmaceutical Market Forecast Analysis

7. Europe Mid-Size Pharmaceutical Market Analysis – by Type

7.1 Prescription
  • 7.1.1 Overview
  • 7.1.2 Prescription: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Over-the-Counter
  • 7.2.1 Overview
  • 7.2.2 Over-the-Counter: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Mid-Size Pharmaceutical Market Analysis – by Drug Development Type

8.1 In-House
  • 8.1.1 Overview
  • 8.1.2 In-House: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Outsource
  • 8.2.1 Overview
  • 8.2.2 Outsource: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Mid-Size Pharmaceutical Market Analysis – by Formulation

9.1 Tablets and Capsules
  • 9.1.1 Overview
  • 9.1.2 Outsource: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Injectables
  • 9.2.1 Overview
  • 9.2.2 Outsource: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Sprays
  • 9.3.1 Overview
  • 9.3.2 Outsource: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Other Formulations
  • 9.4.1 Overview
  • 9.4.2 Outsource: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Mid-Size Pharmaceutical Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Mid-Size Pharmaceutical Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Europe Mid-Size Pharmaceutical Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Mid-Size Pharmaceutical Market Breakdown, by Type
    • 10.1.1.1.2 UK: Europe Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
    • 10.1.1.1.3 UK: Europe Mid-Size Pharmaceutical Market Breakdown, by Formulation
  • 10.1.1.2 Germany: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Mid-Size Pharmaceutical Market Breakdown, by Type
    • 10.1.1.2.2 Germany: Europe Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
    • 10.1.1.2.3 Germany: Europe Mid-Size Pharmaceutical Market Breakdown, by Formulation
  • 10.1.1.3 France: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Mid-Size Pharmaceutical Market Breakdown, by Type
    • 10.1.1.3.2 France: Europe Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
    • 10.1.1.3.3 France: Europe Mid-Size Pharmaceutical Market Breakdown, by Formulation
  • 10.1.1.4 Russia: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Mid-Size Pharmaceutical Market Breakdown, by Type
    • 10.1.1.4.2 Russia: Europe Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
    • 10.1.1.4.3 Russia: Europe Mid-Size Pharmaceutical Market Breakdown, by Formulation
  • 10.1.1.5 Italy: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Mid-Size Pharmaceutical Market Breakdown, by Type
    • 10.1.1.5.2 Italy: Europe Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
    • 10.1.1.5.3 Italy: Europe Mid-Size Pharmaceutical Market Breakdown, by Formulation
  • 10.1.1.6 Rest of Europe: Europe Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Mid-Size Pharmaceutical Market Breakdown, by Type
    • 10.1.1.6.2 Rest of Europe: Europe Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
    • 10.1.1.6.3 Rest of Europe: Europe Mid-Size Pharmaceutical Market Breakdown, by Formulation

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Mid-Size Pharmaceutical Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Alexion Pharmaceuticals, Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bausch Health Companies Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Daiichi Sankyo Company Limited
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Eisai Co., Ltd.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Endo Pharmaceuticals Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Les Laboratories Servier
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Mallinckrodt
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Regeneron Pharmaceuticals, Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Sun Pharmaceutical Industries Ltd
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 UCB S.A.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Europe Mid-Size Pharmaceutical Market

  1. Alexion Pharmaceuticals, Inc.
  2. Bausch Health Companies Inc.
  3. Daiichi Sankyo Company Limited
  4. Eisai Co., Ltd.
  5. Endo Pharmaceuticals Inc.
  6. Les Laboratories Servier
  7. Mallinckrodt
  8. Regeneron Pharmaceuticals, Inc
  9. Sun Pharmaceutical Industries Ltd
  10. UCB S.A.
europe-mid-size-pharmaceutical-market